141 related articles for article (PubMed ID: 38205500)
1. Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Suzuki M; Kikuchi Y; Murakami M
Cureus; 2023 Dec; 15(12):e50343. PubMed ID: 38205500
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
[TBL] [Abstract][Full Text] [Related]
3. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Todate Y; Ishikawa Y; Seto I; Tominaga T; Machida M; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M; Konno S
Strahlenther Onkol; 2023 Mar; 199(3):304-312. PubMed ID: 36446925
[TBL] [Abstract][Full Text] [Related]
5. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
[TBL] [Abstract][Full Text] [Related]
7. Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
Kroese TE; Christ SM; van Rossum PSN; Burger MDL; Buijs GS; Mühlematter U; Andratschke N; Ruurda JP; Hüllner M; Gutschow CA; van Hillegersberg R; Guckenberger M
Radiother Oncol; 2022 Aug; 173():269-276. PubMed ID: 35753555
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
[TBL] [Abstract][Full Text] [Related]
9. Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute.
Oh ES; Moon SH; Lee Y; Ahn BC; Lee JY; Suh YG; Chung JH; Kim MS; Lee JM; Choi JH; Kim TH
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067226
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.
Kim TH; Lee KS; Sim SH; Kim YJ; Kim DY; Chae H; Lee EG; Han JH; Jung SY; Lee S; Kang HS; Lee ES
Front Oncol; 2021; 11():783327. PubMed ID: 34804986
[TBL] [Abstract][Full Text] [Related]
11. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study.
Kroese TE; Jorritsma NKN; van Laarhoven HWM; Verhoeven RHA; Mook S; Haj Mohammad N; Ruurda JP; van Rossum PSN; van Hillegersberg R
Clin Transl Radiat Oncol; 2022 Nov; 37():109-115. PubMed ID: 36186924
[TBL] [Abstract][Full Text] [Related]
13. Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type.
Hu X; Li H; Liu H; Liu Z; Xia T; Zhang J; Wang Y
Transl Cancer Res; 2021 Jan; 10(1):184-194. PubMed ID: 35116250
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors.
Franceschini D; Teriaca MA; Di Cristina L; Vernier V; Lo Faro L; Franzese C; Comito T; Clerici E; Bellu L; Dominici L; Spoto R; Massaro M; Navarria P; Scorsetti M
Br J Radiol; 2023 Mar; 96(1144):20220771. PubMed ID: 36809197
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and Prognostic Factors for Locally Recurrent Rectal Cancer Treated With Proton Beam Therapy.
Takagawa Y; Suzuki M; Yamaguchi H; Seto I; Azami Y; Machida M; Takayama K; Tominaga T; Murakami M
Adv Radiat Oncol; 2023; 8(3):101192. PubMed ID: 36896217
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer.
Hiroshima Y; Ishikawa H; Sumiya T; Murakami M; Nakamura M; Ishida T; Ogawa K; Hisakura K; Mizumoto M; Oda T; Okumura T; Sakurai H
In Vivo; 2023; 37(3):1253-1259. PubMed ID: 37103111
[TBL] [Abstract][Full Text] [Related]
17. Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC.
Farooqi A; Ludmir EB; Mitchell KG; Antonoff MB; Tang C; Lee P; Chang J; Elamin Y; Gomez DR; Gandhi SJ
Radiother Oncol; 2021 Oct; 163():114-118. PubMed ID: 34419505
[TBL] [Abstract][Full Text] [Related]
18. Follow-up study of liver metastasis from breast cancer treated by proton beam therapy.
Fukumitsu N; Okumura T; Numajiri H; Takizawa D; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
Mol Clin Oncol; 2017 Jul; 7(1):56-60. PubMed ID: 28685076
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC).
Gong HY; Wang Y; Han G; Song QB
Thorac Cancer; 2019 May; 10(5):1136-1140. PubMed ID: 30957423
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
